Healwell AI Inc (HAM:6H90)

Q2 2026 Healwell Al Inc Earnings Call Transcript

Aug 7, 2026 / 12:30 PM GMT

Release Date Price: €0.406 (-3.45%)

Transcript

Key Points

Positve

Healwell AI Inc (HWAIF) has successfully navigated the difficult phase of its integration transition and is now seeing the benefits of its enterprise healthcare focus, with a stronger pipeline of potential deals than ever before.
The company maintains a positive adjusted EBITDA, reporting $1.1 million in Q2 2026 and $1.9 million for the first half of 2026, a significant increase of approximately 2,574% year-over-year.
Healwell AI Inc (HWAIF) generated $4.5 million of positive operating cash flow in the first half of 2026, a $14.4 million improvement compared to the prior year, strengthening its balance sheet and liquidity position.
The company's AI capabilities are scaling rapidly, with AI data output overtaking human output for the first time in May, and its AI co-pilots identifying over 62,000 high-risk patients in Q2 alone.
Healwell AI Inc (HWAIF) is seeing strong commercial traction with enterprise deals, with deal sizes now ranging from $1 to $3 million, and is expanding its footprint across key geographies including the Middle East, US, and Canada.
The company's investment in SpaceX has appreciated significantly, with its estimated value rising to approximately $23 million as of June 30, 2026, up from a carrying value of $4.6 million, providing a potential source of capital.

Negative

Healwell AI Inc (HWAIF)'s Q2 2026 revenue was flat year-over-year at $33 million, reflecting an unusually strong Q2 2025 that benefited from elevated project-based professional services activity.
Adjusted EBITDA decreased to $1.1 million in Q2 2026 from $2.3 million in Q2 2025, partly due to the divestiture of Mutual and a stronger number of life science studies in the prior year period.
The company's gross margin slightly declined to 54% in Q2 2026 from 56% in Q2 2025, due to a lower margin mix of studies within the data science and AI segment.
The transition to enterprise sales has elongated sales cycles, causing revenue growth for 2026 to be expected at the lower end of the 30% to 50% range, with a significant portion of AI and data science revenue recognition deferred to the second half of the year.
Subscription revenue for AI technology has declined sequentially, with the company reporting $531,000 in Q2 2026 compared to $828,000 in the prior quarter, raising concerns about the near-term growth trajectory of this segment.
The company's investment in SpaceX remains subject to a customer pre-IPO lockup period, and the timeline for monetizing this position is uncertain, with notification expected in the next month.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AIDX.TO - Healwell Al Inc
Q2 2026 Healwell Al Inc Earnings Call
Aug 07, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for joining Healwell AI's 2026 Second Quarter Financial Results Conference Call.

This call is being recorded.

There will be a question-and-answer session at the end of the call, which will be limited to analysts only. I'll now turn the call over to Mr. Heaven Sain, Investor Relations at Healwell.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Hello, and thank you, operators.

Joining me on the call today are James Lee, CEO of FuelWall, Dr. Alexander Domanowski, President of FuelWall, and Anthony Lam, EOL CFO.

I trust that everyone received a

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.